Remember meForgot password?
    Log in with Twitter

Pharmaceuticals News

Pharmaceutical sector is waking up to big data

Pharmaceutical companies are showing an increased interest in big data, focused on areas like drug discovery and with a realization this can give them a competitive advantage. This might not come so easily, however, without a joined-up strategy.

Pharmaceuticals facing up to data integrity concerns

Pharmaceutical organizations are increasingly reliant upon automated systems and computers, from manufacturing to laboratory release testing. This has brought a renewed regulatory focus on the subject of data integrity.

Pharmaceutical cleaning validation simplified with new software

Washington - The company Quascenta has simplified cleaning validation for active pharmaceutical ingredient manufacturers through a new software package called eResidue. Cleaning validation is a key process, and it avoids cross-contamination.

Old drug sheds a new light on autism

University of California San Diego School of Medicine have completed an early phase clinical trial to evaluate the effectiveness of an established drug for the treatment of autism.

Herbal coffee recalled due to erectile dysfunction additive

Bethesda - A brand of herbal coffee has been recalled from the market after it was discovered that the product contained an unintended active pharmaceutical ingredient, designed to control erectile dysfunction.

Microbiologists assess ways to lower medicine contamination risks Special

Dublin - Microbiologists from a range of pharmaceutical and healthcare companies convened in Dublin to attend a conference discussing how to effectively monitor the built environment for risks in relation to drug product manufacturing.

Microbiologists review best practices for making medicines Special

Birmingham - The manufacture of medicines is at risk from cross-contamination from people, a result of the shedding of microorganisms. In February a special two-day conference considered how best to manage this risk.

Synthetic chemicals — An ignored risk to ecological change

Concerns over the proliferation of synthetic chemicals and pesticides, in particular, gave rise to the environmental movement in the 1960s. But scientific analysis of synthetic chemical pollution and their ecological impacts is disproportionately low.

Most drugs in sewage are not from dumped narcotics

Vermont - The belief that most drugs in sewage are stashes of illegal narcotics flushed down toilets by criminals appears to be a myth. Most drugs in sewage systems are excreted by people who have been prescribed them.

Pharma News: New products and new health initiatives announced

In the latest pharmaceutical news round-up there is a new push to eliminate polio, a new treatment for COPD, and unfortunate news that a patient has died after taking an anti-psychotic medication.

India wants to get in on the oil-for-loans deal with Venezuela

India wants to get in on the oil-for-loans deal that Venezuela has with China, in the hopes of recouping some of the millions of dollars in payments owed to India's largest pharmaceutical companies.

Big AZ takeover and other pharmaceutical news

As we do on a regular basis, Digital Journal has reviewed the latest developments within the pharmaceutical sector. Here AstraZeneca completes takeover of Takeda's respiratory business and Ferring Pharmaceuticals have a new nocturia treatment.

U.S. science center withdraws from sterile products manufacturing

Washington - The U.S. public-sector science base, the National Institutes of Health (NIH), has announced it will suspend all research related to sterile medicinal products after the test areas were found to be out of compliance with good practices.

Mixed news for Novartis

Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.

New leukemia and Zika drugs in the pipeline

Two very different drugs are making progress in news announced this week. The FDA has approved a new leukemia medication, and work is progressing on a Zika virus treatment.

Weekly pharmaceutical news roundup

This week has seen progress updates issued for new drug products for rheumatoid arthritis, skin dermatitis, and for hepatitis. Each of the products is at the clinical trial stage, and three of the drugs on offer are the result of partnerships.

Head of GSK to retire, and other pharma news

The head of GlaxoSmithKline is to retire, amid some concerns about the company’s performance. Digital Journal presents this and other news from the pharmaceutical sector, including mergers and FDA warnings.

List of largest medical fines revealed

The last couple of years have seen a slight lowering in the number of cases brought against medical companies; however, at the same time, there was an increase in the level of fines paid out.

Pharmaceutical sector round-up: Legal action dominates

As we do at regular intervals, Digital Journal dips into the latest news stories relating to the colorful world of pharmaceuticals. This week there are new drugs announced and old scores to settle.

Belgian pharma bosses 'accused of selling to Mexican drug baron'

Brussels - Belgian federal prosecutors are seeking to bring to court seven pharmaceutical executives accused of supplying a Mexican drug baron with the key ingredients for crystal meth, they said Wednesday.

India’s Ipca Laboratories receives FDA warning

Mumbai - The U.S. Food and Drug Administration has issued a warning notice to Ipca Laboratories, which is based in India, for data integrity issues.

Big Pharma wants governments to pay for new antibiotics

Human society needs a new generation of antimicrobials to overcome the problem of multi-drug resistance. A key question stemming from this is who should pick up the bill?

Johnson and Johnson hit by shares drop

U.S. healthcare colossus Johnson and Johnson saw a drop in its share value by 6 percent during 2015, according to the company’s latest financial statement.

FDA takes legal action against pharmaceutical company

Washington - A consent decree has been opened against Downing Labs LLC, of Dallas, Texas, together with the holding company. The action has been initiated by U.S. District Judge Sam A. Lindsay.

Major pharmaceutical companies announce big layoffs

We are only into the early days of 2016 but this hasn’t slowed the actions of companies doing anything to protect their share prices. Two big pharmaceutical companies have already announced plant closures and layoffs.

Most clinical trials today are funded by Big Pharma

Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data suggests this is now the norm rather than the exception.

Pharmaceutical boss arrested in securities fraud

The former, and controversial, CEO of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc., Martin Shkreli, has been detained for securities fraud.

Global drug spending set to rise to $1.4 trillion

In news that will no doubt please the shareholders of pharmaceutical companies, the global spend on drug products is set to rise by 30 percent by the year 2020. This means an annual pay-out of $1.4 trillion.

Many pharma companies failing the clinical trials test

London - The Good Pharma Scorecard is a system that ranks drugs based on their transparency and ethical practices. A review of some big pharma companies reveals several inconsistencies.

FDA blocks imports from Megafine Pharma

The U.S. Food and Drug Administration (FDA) has placed an import ban on the drug maker Megafine Pharma's Nashik site in Maharashtra, India.
  1 2 3 Next»

Set up a news alert for


Pharmaceuticals Image

Eli Lilly s global headquarters  Indianapolis  Indiana
Eli Lilly's global headquarters, Indianapolis, Indiana
Dr. Olumayokun Olajide s research will now look to produce compound derivatives of punicalagin for a...
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's
University of Huddersfield
Biogen is an American global biotechnology company based in Cambridge  Massachusetts  specializing i...
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
A variety of statin drugs
A variety of statin drugs
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
Alexion Pharmaceuticals
Project Team at work:  Expertise helps AbbVie develop and enhance products and therapies to treat co...
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer.
© AbbVie Inc.
Sativex contains marijuana-derived ingredients.
Sativex contains marijuana-derived ingredients.
Associated Press
Medicine vials on display at making Pharmaceuticals 2015.
Medicine vials on display at making Pharmaceuticals 2015.